Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...

The federal Food and Drug Administration has no current plan to bend to pressure from some Republicans to restrict ...

Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on ...

Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the ...

Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...

FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...

The FDA says access to Mifepristone will stay the same — despite safety reviews and pressure from some Republican lawmakers.

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad approval of abortion drugs after the Biden administration expanded their use.

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Mifepristone, which is taken with a second drug, misoprostol, to end an early pregnancy, was first approved by the FDA in 2000 after "a thorough and comprehensive review" determined it was safe ...

Makary has not once stated mifepristone’s proven safety record since the FDA approved it in 2000. The medication has been used safely by over 6 million people in the U.S., according to the agency.

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...